CA2438717C - 6-phenylbenzonaphthyridines - Google Patents
6-phenylbenzonaphthyridines Download PDFInfo
- Publication number
- CA2438717C CA2438717C CA2438717A CA2438717A CA2438717C CA 2438717 C CA2438717 C CA 2438717C CA 2438717 A CA2438717 A CA 2438717A CA 2438717 A CA2438717 A CA 2438717A CA 2438717 C CA2438717 C CA 2438717C
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- hydrogen
- radical
- formula
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Luminescent Compositions (AREA)
- Electroluminescent Light Sources (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01104086 | 2001-02-21 | ||
| EP01104086.2 | 2001-02-21 | ||
| PCT/EP2002/001819 WO2002066476A1 (en) | 2001-02-21 | 2002-02-21 | 6-phenylbenzonaphthyridines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2438717A1 CA2438717A1 (en) | 2002-08-29 |
| CA2438717C true CA2438717C (en) | 2011-08-30 |
Family
ID=8176545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2438717A Expired - Fee Related CA2438717C (en) | 2001-02-21 | 2002-02-21 | 6-phenylbenzonaphthyridines |
Country Status (12)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004018431A2 (en) * | 2002-08-17 | 2004-03-04 | Altana Pharma Ag | Novel phenanthridines |
| PL373598A1 (en) * | 2002-08-17 | 2005-09-05 | Altana Pharma Ag | Novel benzonaphthyridines |
| ATE353217T1 (de) | 2002-08-29 | 2007-02-15 | Altana Pharma Ag | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren |
| DE60313331T2 (de) * | 2002-09-04 | 2008-01-03 | Nycomed Gmbh | Neue benzonaphthyridine |
| US7470704B2 (en) | 2002-09-04 | 2008-12-30 | Nycomed Gmbh | Benzonaphthyridines |
| EP1720835B1 (en) | 2004-02-18 | 2012-12-12 | Nycomed GmbH | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors |
| CN104817534A (zh) | 2004-03-03 | 2015-08-05 | 塔科达有限责任公司 | 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途 |
| AR049419A1 (es) * | 2004-03-03 | 2006-08-02 | Altana Pharma Ag | Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo |
| MXPA06009892A (es) * | 2004-03-10 | 2007-03-01 | Altana Pharma Ag | Nuevas hidroxi-6-fenilfenantridinas sustituidas con amido y su uso como inhibidores de la fosfodiesterasa tipo 4 (pde4). |
| US7671068B2 (en) | 2004-03-17 | 2010-03-02 | Nycomed Gmbh | N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors |
| NZ560268A (en) | 2005-03-02 | 2010-12-24 | Nycomed Gmbh | Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives |
| WO2018069210A1 (en) | 2016-10-10 | 2018-04-19 | Takeda Gmbh | Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9713338B1 (pt) * | 1996-11-11 | 2009-12-01 | benzonaftiridinas, medicamento, bem como seu uso como terapêuticos brÈnquicos. | |
| JP2001514640A (ja) * | 1997-03-07 | 2001-09-11 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | 新規のテトラゾール |
| ATE232864T1 (de) | 1997-06-03 | 2003-03-15 | Altana Pharma Ag | Benzonaphthyridine |
| ES2195571T3 (es) | 1998-05-05 | 2003-12-01 | Altana Pharma Ag | Nuevos benzonaftiridin-n-oxidos. |
| ATE269331T1 (de) * | 1998-08-31 | 2004-07-15 | Altana Pharma Ag | Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität |
-
2002
- 2002-02-21 WO PCT/EP2002/001819 patent/WO2002066476A1/en active IP Right Grant
- 2002-02-21 PT PT02722110T patent/PT1377574E/pt unknown
- 2002-02-21 JP JP2002565990A patent/JP4248245B2/ja not_active Expired - Fee Related
- 2002-02-21 US US10/467,568 patent/US6936622B2/en not_active Expired - Fee Related
- 2002-02-21 DE DE60202669T patent/DE60202669T2/de not_active Expired - Lifetime
- 2002-02-21 ES ES02722110T patent/ES2236504T3/es not_active Expired - Lifetime
- 2002-02-21 CA CA2438717A patent/CA2438717C/en not_active Expired - Fee Related
- 2002-02-21 AU AU2002253045A patent/AU2002253045B2/en not_active Ceased
- 2002-02-21 AT AT02722110T patent/ATE287403T1/de active
- 2002-02-21 DK DK02722110T patent/DK1377574T3/da active
- 2002-02-21 SI SI200230083T patent/SI1377574T1/xx unknown
- 2002-02-21 EP EP02722110A patent/EP1377574B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1377574A1 (en) | 2004-01-07 |
| SI1377574T1 (US07727997-20100601-C00033.png) | 2005-08-31 |
| ATE287403T1 (de) | 2005-02-15 |
| ES2236504T3 (es) | 2005-07-16 |
| EP1377574B1 (en) | 2005-01-19 |
| WO2002066476A1 (en) | 2002-08-29 |
| DE60202669T2 (de) | 2005-09-15 |
| US20040097537A1 (en) | 2004-05-20 |
| DK1377574T3 (da) | 2005-04-25 |
| CA2438717A1 (en) | 2002-08-29 |
| PT1377574E (pt) | 2005-05-31 |
| AU2002253045B2 (en) | 2007-07-12 |
| DE60202669D1 (de) | 2005-02-24 |
| JP2004526712A (ja) | 2004-09-02 |
| WO2002066476A9 (en) | 2003-10-30 |
| JP4248245B2 (ja) | 2009-04-02 |
| US6936622B2 (en) | 2005-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6306869B1 (en) | N-oxides | |
| AU2003258576B2 (en) | Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors | |
| WO2004018465A9 (en) | Benzonaphthyridines with pde 3/4 inhibiting activity | |
| JP4223075B2 (ja) | 気管支治療薬としてのベンゾナフチリジン | |
| AU2003253408A1 (en) | Novel phenanthridines | |
| AU2003260371A1 (en) | Piperidine-n-oxide-derivatives | |
| CA2438717C (en) | 6-phenylbenzonaphthyridines | |
| US7671068B2 (en) | N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors | |
| US6214839B1 (en) | Substituted 6-alkylphenanthridines | |
| AU2002253045A1 (en) | 6-phenylbenzonaphthyridines | |
| BG108187A (bg) | Пиперазино производни и приложението им като pde4 инхибитори | |
| EP1537109B1 (en) | Novel benzonaphthyridines | |
| US6306867B1 (en) | Imidazo- and oxazolopyridines | |
| US8198295B2 (en) | Benzonaphthyridines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20170221 |